共 118 条
[1]
Forner A(2012)Hepatocellular carcinoma Lancet 379 1245-1255
[2]
Llovet JM(2012)EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma J Hepatol 56 908-943
[3]
Bruix J(2014)Systemic therapy for hepatocellular carcinoma: the issue of treatment stage migration and registration of progression using the BCLC-refined RECIST Semin Liver Dis 34 444-455
[4]
Reig M(2011)Management of hepatocellular carcinoma: an update Hepatology 53 1020-1022
[5]
Darnell A(2017)ADCtotal ratio and D ratio derived from intravoxel incoherent motion early after TACE are independent predictors for survival in hepatocellular carcinoma J Magn Reson Imaging 46 820-830
[6]
Forner A(2016)Predictive values of diffusion-weighted imaging and perfusion-weighted imaging in evaluating the efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma Onco Targets Ther 9 7029-7037
[7]
Rimola J(2014)Using intravoxel incoherent motion (IVIM) MR imaging to predict lipiodol uptake in patients with hepatocellular carcinoma following transcatheter arterial chemoembolization: a preliminary result Magn Reson Imaging 32 638-646
[8]
Ayuso C(2016)Potential of MR histogram analyses for prediction of response to chemotherapy in patients with colorectal hepatic metastases Eur Radiol 26 2009-2018
[9]
Bruix J(2017)Whole-lesion histogram analysis of the apparent diffusion coefficient: Evaluation of the correlation with subtypes of mucinous breast carcinoma J Magn Reson Imaging 47 391-400
[10]
Bruix J(2017)Whole-lesion histogram analysis metrics of the apparent diffusion coefficient as a marker of breast lesions characterization at 1.5 T Radiography (Lond) 23 e41-e46